Baraldo, Simonetta
Bonato, Matteo
Cassia, Sebastiano
Casolari, Paolo
De Ferrari, Laura
Tiné, Mariaenrica
Baraldi, Federico
Bigoni, Tommaso
Riccio, Anna Maria
Braido, Fulvio
Saetta, Marina
Papi, Alberto
Contoli, Marco
Article History
Received: 19 December 2023
Accepted: 13 August 2024
First Online: 19 August 2024
Declarations
:
: The study conformed to the Declaration of Helsinki. Local ethics committee approval was obtained for sampling collection (Comitato Etico Azienda Ospedaliero Univeristaria Ferrara, Ferrara, Italy. Ref. number 080399 – Approved in March 2018). Informed written consent was obtained from each participant.
: Not Applicable.
: <b>SB</b> has nothing to declare. <b>MB</b> has nothing to declare. <b>SC</b> has nothing to declare. <b>PC</b> has nothing to declare. <b>LDF</b> has nothing to declare. <b>MT</b> has nothing to declare. <b>FeBa</b> has nothing to declare. <b>TB</b> has nothing to declare. <b>AMR</b> has nothing to declare. <b>FuBr</b> declares personal payments for participation on Advisory Board from ASTRAZENECA, BOEHRINGER INGELHEIM, CHIESI, GSK, MENARINI GROUP, SANOFI, P&G; personal payments or honoraria for lectures, presentations from ASTRAZENECA, BOEHRINGER INGELHEIM, CHIESI, GSK, MENARINI GROUP, SANOFI. <b>MS</b> has nothing to declare. <b>A.P.</b> declares: research grants from CHIESI, ASTRAZENECA, GSK, SANOFI, Agenzia Payments Italiana del farmaco (AIFA); personal payments for consultation from Chiesi, ASTRAZENECA, GSK, NOVARTIS, SANOFI, AVILLION, ELPEN PHARMACEUTICA; Personal payments for lectures, presentations, or educational events from CHIESI, ASTRAZENECA, GSK, MENARINI, NOVARTIS, ZAMBON, MUNDIPHARMA, SANOFI, EDMOND PHARMA, IQVIA, AVILLION, ELPEN PHARMACEUTICALS; Personal payments for Advisory boards: CHIESI, ASTRAZENECA, GSK, MSD, NOVARTIS, SANOFI, IQVIA, AVILLION, ELPEN PHARMACEUTICALS; nothing to declare related to the present manuscript. <b>M.C</b> declares: research grants from Chiesi and GSK; personal payments for lectures, presentations or educational events from CHIESI, ASTRAZENECA, GSK, NOVARTIS, ZAMBON, SANOFI, ALK ABELLO; personal payments for participation on Advisory Board from CHIESI, ASTRAZENECA, GSK, ALK ABELLO, SANOFI; nothing to declare related to the present manuscript. All of the authors contributed to the study implementation, as well as to the development of this report.